141 related articles for article (PubMed ID: 20942170)
1. [Anti-survivin and anti-livin antibodies].
Yagihashi A
Nihon Rinsho; 2010 Jun; 68 Suppl 6():708-10. PubMed ID: 20942170
[No Abstract] [Full Text] [Related]
2. [Immunologic tests: Anti-Survivin and anti-Livin antibodies].
Yagihashi A
Nihon Rinsho; 2005 Jul; 63 Suppl 7():637-9. PubMed ID: 16111355
[No Abstract] [Full Text] [Related]
3. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
[TBL] [Abstract][Full Text] [Related]
4. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
[TBL] [Abstract][Full Text] [Related]
5. [Detection of autoantibody against cancer antigen and its clinical application].
Yagihashi A
Nihon Naika Gakkai Zasshi; 2006 Jul; 95(7):1382-6. PubMed ID: 16893037
[No Abstract] [Full Text] [Related]
6. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients.
Kitamura H; Honma I; Torigoe T; Hariu H; Asanuma H; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2007 Jul; 70(1):38-42. PubMed ID: 17656204
[TBL] [Abstract][Full Text] [Related]
7. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
Söling A; Plugge EM; Schmitz M; Weigle B; Jacob R; Illert J; Holzhausen HJ; Rainov NG
Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitor of apoptosis in lung cancer Livin perioperative clinical research].
Wang LN; Mou J; Zhang YB; Dong P; Diao X; Wang SY; Chen H; Liu YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Sep; 26(9):889-90. PubMed ID: 20815986
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.
Rohayem J; Diestelkoetter P; Weigle B; Oehmichen A; Schmitz M; Mehlhorn J; Conrad K; Rieber EP
Cancer Res; 2000 Apr; 60(7):1815-7. PubMed ID: 10766164
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
[TBL] [Abstract][Full Text] [Related]
13. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
[TBL] [Abstract][Full Text] [Related]
14. [Anti-calmodulin antibody].
Hashimoto N; Ikeda Y; Toda G
Nihon Rinsho; 2010 Jun; 68 Suppl 6():697-700. PubMed ID: 20942167
[No Abstract] [Full Text] [Related]
15. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
Eto M; Kodama S; Uemura N; Suzuki M
Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
[TBL] [Abstract][Full Text] [Related]
16. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
Kleinberg L; Flørenes VA; Nesland JM; Davidson B
Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312
[TBL] [Abstract][Full Text] [Related]
17. Anti-livin antibodies: novel markers of malignant gastrointestinal cancers.
El Ali Z; Grzymisławski M; Majewski P; Baumann-Antczak A; Kosowicz J
Pol Arch Med Wewn; 2010; 120(1-2):26-9. PubMed ID: 20150841
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
[TBL] [Abstract][Full Text] [Related]
19. [Anti-GM-CSF autoantibodies (GM-CSF autoantibodies)].
Watanabe M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():684-6. PubMed ID: 20942163
[No Abstract] [Full Text] [Related]
20. [Immunological tests: Anti desmoglein 1 and 3 antibody].
Amagai M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():571-4. PubMed ID: 16111335
[No Abstract] [Full Text] [Related]
[Next] [New Search]